Browse > Article

Cardiomyogenic Potential of Human Adipose Tissue and Umbilical Cord Derived-Mesenchymal Like Stem Cells  

Park, Se-Ah (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
Kang, Hyeon-Mi (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
Kim, Eun-Su (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
Kim, Jin-Young (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
Kim, Hae-Kwon (Department of Biotechnology, College of Natural Sciences, Seoul Women's University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.34, no.4, 2007 , pp. 239-252 More about this Journal
Abstract
Objectives: In the present study, we examined the differentiation potential of human adipose-(HAD) and human umbilical cord-derived mesenchymal like stem cells (HUC) into cardiomyocytes. Methods: Cells were initially exposed to 5-azacytidine for 24h cells and then were cultivated in the presence or absence of activin A, TGF-$\beta$1, or Wnt inhibitor with various combinations of BMP and FGF. Assessment of cardiomyogenic differentiation was made upon the expression of cardiomyocyte-specific genes using RT-PCR. Results: HAD that cultivated in control medium for 4 weeks after 5-azacytidine expose showed new expression of TnT gene and increased expression of Cmlc1 and kv4.3 genes. However, HAD cultivated in the presence of combinations of BMP-4/FGF-4 (B4/F4) and BMP-4/FGF-8 (B4/F8) showed new expression of $\beta$-MHC gene and more increased expression of Cmlc1, TnT, TnI, Kv4.3 genes. Significantly enhanced expression of Cmlc1, TnT, and Kv4.3 genes were also observed compared to that cultivated in the control medium. Treatment of HUC with either 5-azacytidine or combinations of BMP and FGF did not affect the expression profile of these genes. However, when activin A or TGF-$\beta$1 was present in addition to the BMP-2/FGF-8 (B2/F8) after 5-azacytidine exposure, HUC exhibited new expression of $\beta$-MHC gene and increased expression of $\alpha$-CA, TnT and Kv4.3 genes. When Wnt inhibitor was present in addition to BMP and FGF, HUC showed new expression of Cmlc1 gene and increased expression of $\alpha$-CA, TnT, TnI and Kv4.3 genes. Conclusions: Based on these observations, it is suggested that HAD and HUC could differentiate into cardiomyocytes which might be used as therapeutic cells for the heart diseases.
Keywords
Mesenchymal stem cells; Adipose tissue-derived stem cells; Umbilical cord-derived stem cells; Cardiomyocyte; Gene expression; HAD; HUC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Solloway MJ, Harvey RP. Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc Res 2003; 58: 264-77   DOI   ScienceOn
2 Saga Y, Kitajima S, Miyagawa-Tomita S. Mespl expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med. 2000; 10: 345-52   DOI   ScienceOn
3 Terami H, Hidaka K, Katsumata T, Iio A, Morisaki T. Wntll facilitates embryonic stem cell differentiation to Nkx2.5positive cardiomyocytes. Biochem Biophys Res Commun. 2004; 325: 968-75   DOI   ScienceOn
4 Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002 May 31; 90: 1044-54
5 Zuk PA, ZhuM, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-95   DOI   ScienceOn
6 Xu W, Zhang X, Qian H. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004; 229: 623-31   DOI
7 Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Bio Chem Biophys Res Commun 2006; 340: 639-47   DOI   ScienceOn
8 Shim WS, Jiang S, Wong P, Tan J, Chua YL, Tan YS, et at. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2004; 324: 481-8   DOI   ScienceOn
9 Andree B, Duprez D, Vorbusch B, Arnold HH, Brand T. BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech Dev 1998; 70: 119-31   DOI   PUBMED   ScienceOn
10 Ladd AN, Yatskievych TA, Antin PB. Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins. Dev Biol 1998; 204: 407-19   DOI   ScienceOn
11 Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 225: 649-58
12 Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-24   DOI   ScienceOn
13 Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007; 105: 215-28   DOI   ScienceOn
14 Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16: 381-90   PUBMED
15 Dirnmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-83   DOI   PUBMED
16 Pandur P, Lasche M, Eisenberg LM, Kiihl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002; 418: 636-41   DOI   ScienceOn
17 Zimmermann WH, Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 2007; 17: 134-40   DOI   ScienceOn
18 Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 15: 3174-83
19 In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willernze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-9   DOI   PUBMED   ScienceOn
20 Bin Z, Sheng LG, Gang ZC, Hong J, Jun C, Bo Y, et at. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 2006; 30: 769-76   DOI   ScienceOn
21 Tsuji-Takayama K, Inoue T, Ijiri Y, Otani T, Motoda R, Nakamura S, et at. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Biochem Biophys Res Commun 2004; 323: 86-90   DOI   ScienceOn
22 He JQ, Ma Y, Lee Y, Thomson JA, Karnp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93: 32-9   DOI   ScienceOn
23 Ye NS, Zhang RL, Zhao YF, Feng X, Wang YM, Luo GA. Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro. Genomics Proteomics Biolnformatics. 2006; 4: 18-25   DOI   ScienceOn
24 Alsan BH, Schultheiss TM. Regulation of avian cardiogenesis by FGF8 signaling. Development 2002; 129: 1935-43   PUBMED
25 Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105-10   DOI   ScienceOn
26 Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007; 93: 1278-84   DOI   PUBMED
27 Ilagan R, Abu-Issa R, Brown D, Yang YP, Jiao K, Schwartz RJ, et al. Fgf8 is required for anterior heart field development. Development. 2006; 133: 2435-45   DOI   ScienceOn
28 Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329: 209-23   DOI   PUBMED
29 He X. A Wnt-Wnt situation. Dev Cell 2003; 4: 791-7   DOI   PUBMED   ScienceOn
30 Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res 2007; 101: 1139-45   DOI   ScienceOn
31 Wang YX, Qian LX, Liu D, Yao LL, Jiang Q, Yu Z, et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 2007; 74: 290-303   DOI   ScienceOn
32 Barron M, Gao M, Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 2000; 218: 383-93   DOI   ScienceOn
33 Prindull G, Prindull B, Meulen N. Haematopoietic stem cells (CFUc) in human cord blood 1978; 67: 413-6
34 Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 2006; 68: 29-49   DOI   ScienceOn
35 Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, et al. Mesecnchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2: 477-88   DOI   ScienceOn
36 Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997; 272: 220-6
37 Balana B, Nicoletti C, Zahanich I, Graf EM, Christ T, Boxberger S, et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res 2006; 16: 949-60   DOI   ScienceOn
38 Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005; 79: 528-35   DOI   ScienceOn
39 Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 9: 501-8